WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Short Interest Update

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) was the recipient of a significant decrease in short interest during the month of April. As of April 15th, there was short interest totaling 24,485 shares, a decrease of 82.6% from the March 31st total of 140,652 shares. Based on an average daily trading volume, of 107,227 shares, the short-interest ratio is currently 0.2 days. Approximately 0.0% of the company’s stock are short sold.

WuXi Biologics (Cayman) Trading Down 0.1%

OTCMKTS:WXXWY traded down $0.01 during mid-day trading on Friday, reaching $8.54. The stock had a trading volume of 32,840 shares, compared to its average volume of 63,502. The business’s 50 day moving average is $9.22 and its 200 day moving average is $9.11. WuXi Biologics has a fifty-two week low of $5.50 and a fifty-two week high of $11.21.

WuXi Biologics (Cayman) Company Profile

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.